dienogest has been researched along with Activated Protein C Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballieux, B; Helmerhorst, F; Raps, M; Rosendaal, F; Rosing, J; Thomassen, S; van Vliet, H | 1 |
| Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M | 1 |
2 trial(s) available for dienogest and Activated Protein C Resistance
| Article | Year |
|---|---|
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Nandrolone; Sex Hormone-Binding Globulin; Young Adult | 2013 |
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult | 2011 |